Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with resectable non-small cell lung cancer at least 4 cm or node positive and no known EGFR mutation or ALK rearrangement; durvalumab with platinum chemotherapy before surgery and alone afterward.
LAMPGEN ANALYSIS
Why it matters
The AEGEAN-based approval added another perioperative option for the defined population without known EGFR or ALK drivers.
What research teams should watch
Map the treatment and surgery sequence in the source record, including delays, cancellations and whether postoperative treatment began.
PRIMARY RECORDS